EXCLUSIVE: The pharmaceutical giant is re-entering the obesity market and aims to become a top-three player, rivaling the likes of Eli Lilly and Novo Nordisk.
Source link
About The Author
Roche Bets Splits in Obesity Market Will Open Door to New Entrants